The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative...

Area of Science:

• Cardiology
• Public Health
• Pharmacology

Background:

• Hypertension is a leading cause of death in Colombia, with high awareness but suboptimal blood pressure control.
• Current Colombian guidelines differ from international recommendations, potentially hindering effective hypertension management.
• Therapeutic inertia and underutilization of recommended combination therapies are significant issues in Colombian hypertension care.

Purpose of the Study:

• To review the rationale for using single-pill combinations (SPCs) for hypertension treatment in Colombia.
• To examine major challenges in blood pressure control within the Colombian context.
• To assess the potential of SPCs in improving adherence and outcomes.

Main Methods:

• Narrative review of existing literature and guidelines.
• Analysis of hypertension management practices in Colombia.
• Examination of factors influencing treatment adherence and blood pressure control.

Main Results:

• Colombian guidelines recommend diuretic monotherapy initially, contrasting with international combination therapy recommendations.
• Widespread therapeutic inertia and underutilization of first-line agents like ACE inhibitors and CCBs are prevalent.
• Low adherence to antihypertensive therapy is a key issue, potentially improved by SPCs, education, and follow-up.

Conclusions:

• Single-pill combinations (SPCs) are available and recommended for improving adherence and overcoming therapeutic inertia in Colombia.
• Implementing SPCs can contribute to better blood pressure control and reduced cardiovascular mortality.
• Further physician-led initiatives are needed alongside national programs to enhance hypertension management.